Nanophase Technologies Corporation  (NANX)
Other Ticker:  
Price: $0.6400 $-0.06 -8.571%
Day's High: $0.7 Week Perf: -14.67 %
Day's Low: $ 0.60 30 Day Perf: -29.67 %
Volume (M): 12 52 Wk High: $ 1.80
Volume (M$): $ 8 52 Wk Avg: $1.15
Open: $0.70 52 Wk Low: $0.32

 Market Capitalization (Millions $) 32
 Shares Outstanding (Millions) 50
 Employees 46
 Revenues (TTM) (Millions $) 37
 Net Income (TTM) (Millions $) -4
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 2

Nanophase Technologies Corporation

Nanophase Technologies Corporation is an advanced materials and applications developer and commercial manufacturer with an integrated family of materials technologies. We produce engineered nano and sub-micron materials for use in a variety of diverse markets: personal care including sunscreens, architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics, energy and a variety of surface finishing technologies (polishing) applications, including optics.

While our origin is based on the creation of nanoscale metal oxide products, we have expanded our offerings to include larger but still sub-micron materials. We have developed techniques for managing attributes including particle size, shape, surface coatings, and other valuable aspects of the material. Our focus is on customer need where we believe we have an advantage, as opposed to finding uses for one particular technology. Additionally, as the format of delivery is important to customers, we have developed proprietary capabilities for dispersing our materials into both aqueous (water-based) and solvent-based liquid media. These capabilities allow us to better integrate with the customer’s need and application. Finally, we have expanded our offerings beyond active ingredients to include targeted full formulations of skin care products, marketed and sold by our wholly-owned subsidiary, Solésence ™ LLC.

We target markets in which we believe practical solutions may be found using our products. We work closely with current and potential customers in these target markets to identify their material and performance requirements. We market our materials to various end-use applications manufacturers and our Solésence ™ solutions to cosmetic and skin care brands. Recently developed technologies have made certain new products possible and opened potential new markets. We expect growth in end-user (manufacturing customers, including customers of our customers) adoption in 2017 and beyond. Our initiatives in targeted market areas are progressing at differing rates of speed, but we have been broadly moving through testing and development cycles, and in a number of cases believe we are approaching first revenue or next stage revenue with particular customers in the industries referenced above. During 2015 we were granted a patent on a new type of particle surface treatment (coating), which became the cornerstone of our new product development in personal care, with first revenue recognized during 2016 and the creation of our Solésence ™ LLC subsidiary to manufacture and sell fully developed solutions to targeted customers in the skin care industry, in addition to the additives we have traditionally sold in the personal care area.

We have created a leading commercial approach to the application of our integrated materials technologies designed to deliver an optimal engineered solution for a target market or specific customer application. With respect to our products, we have complete capability from application development and laboratory samples through pilot production and, finally, commercial production currently at rates as high as hundreds of metric tons per year for individual products. We have development and application laboratories and manufacturing capacity in two locations in the Chicago area. Our manufacturing is based on Lean Six Sigma discipline and is certified to ISO 9001, American National Standard, Quality Management System Requirements; ISO 14001, American National Standard, Environmental Management System Requirements; and is compliant with current Good Manufacturing Practices (“cGMP”) for products under U.S. Food and Drug Administration (“FDA”) regulation.

We have undergone a strategic shift during recent years toward penetrating key markets via interactive applications development with end-use customers in these markets. We also supply both nanoscale and larger materials, based on market requirement. We believe this strategy leverages the applications development expertise we have cultivated over the last several years and best positions us to build direct sales to end-use customers, in addition to translating these advantages through our market partners.

Our efforts in research and development, process engineering and advanced engineering groups are focused in three major areas: 1) application development for our products; 2) creating or obtaining additional core material technologies and/or materials that have the capability to serve multiple markets; and 3) continuing to improve our core technologies to improve manufacturing operations and reduce costs.

Most of our research and development is directly related to applications development. We endeavor to either meet specific customer needs or to develop applications solutions to address unmet needs in a particular market where we believe our materials will offer a distinct performance advantage. We believe that aggressively pursuing applications in targeted areas will help us compete as a technical and commercial innovator using our materials expertise, and more importantly, become perceived as a solutions provider by our customers and not simply as another materials supplier.

   Company Address: 1319 Marquette Drive Romeoville 60446 IL
   Company Phone Number: 771-6708   Stock Exchange / Ticker: NANX
   NANX is expected to report next financial results on March 28, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
LIQT   -7.25%    
MTRN        3.59% 
NUGN   -4.76%    
SCIA   -2.3%    
VIAV        7.54% 
• View Complete Report

Safety Shot Inc

The Personal and Household Products company reported very demanding period, in the most recent fiscal period

Safety Shot Inc (SHOT) recently reported a disastrous fiscal period, marked by significant decline in revenue and an expanded net deficit per share compared to the previous reporting season. This article aims to delve deeper into SHOT's financial performance and provide an explanation for the contrasting scenario in the Personal and Household Products sector, which witnessed a modest improvement in the third quarter of 2023.
Revenue Decline and Net Deficit per Share Expansion
SHOT experienced a staggering decline in revenue during the most recent fiscal period, with a slump of -69.158% to $0.48 million. This decline is significant when compared to the same reporting season a year ago. Additionally, the net deficit per share has expanded to $-0.26, a considerable increase from the previous year.

Dswiss Inc

DQWS Earnings Season: Unveiling a Stunning Slump in Revenue for Q3 2023

DQWS, a leading company in the industry, recently released its financial results for the period ending September 30, 2023. The figures present an intriguing story of fluctuating revenues, declining net earnings, and contrasting inventory and accounts receivable levels. As we delve into the details, it becomes critical to assess how these numbers may impact the future of DQWS.
Challenging Revenue Trend:
The most significant observation in DQWS's financial report is the -41.637% decline in revenue compared to the previous year, amounting to $0.43 million in the current reporting period, down from $0.73 million a year before. However, the sequential comparison shows a positive trend, with revenue increasing by 19.786% from $0.36 million. This sequential improvement brings some hope for future growth potential.

Edgewell Personal Care Company

Headline: Edgewell Personal Care Company's Fourth Quarter 2023 Top-line Remains Unaltered in a Mixed Bag Performance

Edgewell Personal Care Company, a prominent player in the Personal and Household Products industry, released its financial results for the quarter ended September 30, 2023. The company's performance was a mixed bag, with some positive developments but also areas of concern.
Let's delve into the numbers to gain a better understanding of how Edgewell fared during this period. The company reported a loss of $0.17 per share, marking an improvement from the deficit of $0.91 per share recorded in the same quarter the previous year. However, compared to the preceding quarter, where earnings per share stood at $1.01, there was a significant decline.

Eos Inc

Eos Inc. Grapples with Massive Losses, Faces Severe Hit During Third Quarter of 2023

Eos Inc Struggles to Find Stability Amidst Revenue Drop and Declining Finances
In the financial period ending September 30, 2023, Eos Inc disclosed its financial results, showcasing a concerning trend for the struggling company. With balanced books reaching a disappointing $0.00 per share, compared to the same period last year, and the previous financial reporting period, it signals a lack of growth and stability within the organization.
The company's revenue took a sharp plunge, declining by a staggering -88.056% to $0.04 million from $0.30 million in the corresponding financial period a year ago. Additionally, the sequential revenue drop was recorded at -56.528% from $0.08 million, indicating a significant decline in product demand and market performance.

Nanophase Technologies Corporation

Nanophase Technologies Corporation's Shares Surge Despite Challenging Q3 Financials with -22.195% Revenue Decline

Nanophase Technologies Corporation, a nanomaterials and advanced materials company, has recently witnessed solid gains in its shares. However, the company's financial results for the third quarter of 2023 reveal weak demand, leading to increased losses. This article will interpret the impact of these results on Nanophase Technologies Corporation's future prospects.
Financial Results:
The third quarter of 2023 financial report presented a mixed picture for Nanophase Technologies Corporation. Despite recording a net loss per share of $-0.03, slightly higher than the previous year's $-0.02, the company's shares saw a solid gain of 7.87% over the past week. However, the company's revenue suffered a significant drop of -22.195%, amounting to $7.53 million, down from $9.68 million a year prior.


Nanophase Technologies's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com